Download Files:
GSK-3β inhibitor 14
SKU
HY-153760-1mg
Category Reference compound
Tags GSK-3, Metabolic Disease; Neurological Disease, PI3K/Akt/mTOR;Stem Cell/Wnt
$313
Only 1000 item(s) left in stock.
Products Details
Product Description
– GSK-3β inhibitor 14 (Compound 6i), benzothiazepinone derivative, is a weak GSK-3β inhibitor (IC50 >100 μM)[1].
Web ID
– HY-153760
Shipping
– Room temperature
Molecular Formula
– C17H17NOS
References
– [1]Zhang P, et al. Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β). Eur J Med Chem. 2013 Mar;61:95-103.
CAS Number
– 863004-48-2
Molecular Weight
– 283.39
SMILES
– O=C1CC(C)SC2=CC=CC=C2N1CC3=CC=CC=C3
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– GSK-3
Pathway
– PI3K/Akt/mTOR;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.